Viracta Therapeutics, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Viracta Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q3 2024.
  • Viracta Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$10.6M, a 16.2% increase year-over-year.
  • Viracta Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$43.3M, a 9.09% increase year-over-year.
  • Viracta Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$51.1M, a 3.78% decline from 2022.
  • Viracta Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$49.2M, a 57.1% increase from 2021.
  • Viracta Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$115M, a 503% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$43.3M -$10.6M +$2.05M +16.2% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 -$45.3M -$9.83M +$2.65M +21.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-13
Q1 2024 -$48M -$9.14M +$3.07M +25.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-13
Q4 2023 -$51.1M -$13.8M -$3.44M -33.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-07
Q3 2023 -$47.6M -$12.6M +$5.14M +29% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 -$52.8M -$12.5M -$1.9M -18% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-13
Q1 2023 -$50.9M -$12.2M -$1.66M -15.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-13
Q4 2022 -$49.2M -$10.3M +$1.12M +9.79% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-07
Q3 2022 -$50.3M -$17.7M -$2.83M -19% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$47.5M -$10.6M -$1.41M -15.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-09
Q1 2022 -$46.1M -$10.5M +$68.7M +86.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-09
Q4 2021 -$115M -$11.4M -$5.16M -82.1% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-14
Q3 2021 -$110M -$14.9M -$10.8M -266% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$98.8M -$9.17M -$4.93M -116% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-10
Q1 2021 -$93.8M -$79.2M -$74.8M -1694% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-10
Q4 2020 -$19M -$6.29M -$10.8M -240% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-17
Q3 2020 -$8.25M -$4.08M +$1.86M +31.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$10.1M -$4.24M +$2.01M +32.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-10
Q1 2020 -$12.1M -$4.42M +$1.44M +24.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-10
Q4 2019 -$13.6M $4.48M +$10.5M Oct 1, 2019 Dec 31, 2019 8-K/A 2021-03-23
Q3 2019 -$24M -$5.94M +$563K +8.66% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 -$24.6M -$6.24M +$599K +8.76% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-11
Q1 2019 -$25.2M -$5.86M +$1.41M +19.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 -$26.6M -$6M +$626K +9.45% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-10
Q3 2018 -$27.2M -$6.51M +$3.65M +36% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$30.9M -$6.84M +$2M +22.6% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 -$32.9M -$7.27M +$2.56M +26% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 -$35.5M -$6.62M +$1.91M +22.4% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-07
Q3 2017 -$37.4M -$10.2M -$1.21M -13.5% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-05
Q2 2017 -$36.2M -$8.84M +$1.6M +15.4% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 -$37.8M -$9.83M +$252K +2.5% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 -$38M -$8.54M +$3.04M +26.3% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-09
Q3 2016 -$41.1M -$8.95M -$1.93M -27.5% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-02
Q2 2016 -$39.1M -$10.4M -$1.5M -16.7% Apr 1, 2016 Jun 30, 2016 10-Q 2017-07-27
Q1 2016 -$37.6M -$10.1M -$958K -10.5% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-08
Q4 2015 -$36.7M -$11.6M -$10.3M -775% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-09
Q3 2015 -$26.4M -$7.02M +$8.3M +54.2% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-03
Q2 2015 -$34.7M -$8.95M +$2.83M +24% Apr 1, 2015 Jun 30, 2015 10-Q 2016-07-29
Q1 2015 -$37.6M -$9.13M +$5.45M +37.4% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 -$43M -$1.32M +$5.85M +81.6% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-09
Q3 2014 -$48.9M -$15.3M -$7.72M -101% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 -$41.1M -$11.8M -$3.59M -43.8% Mar 31, 2014 Jun 30, 2014 10-Q 2015-07-30
Q1 2014 -$37.5M -$14.6M -$2.95M -25.4% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-05
Q4 2013 -$34.6M -$7.18M -$3.13M -77.1% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-14
Q3 2013 -$31.5M -$7.61M +$9.79M +56.3% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 -$41.3M -$8.19M +$389K +4.53% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-05
Q1 2013 -$41.7M -$11.6M +$2.3M +16.5% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-07
Q4 2012 -$44M -$4.05M +$4.69M +53.6% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-12
Q3 2012 -$48.6M -$17.4M -$12.4M -247% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 -$36.3M -$8.58M -$352K -4.28% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-02
Q1 2012 -$35.9M -$13.9M -$15.8M -857% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q4 2011 -$20.1M -$8.74M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-06
Q3 2011 -$5.01M +$70K +1.38% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-08
Q2 2011 -$8.23M -$3.44M -72% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
Q1 2011 $1.84M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
Q3 2010 -$5.08M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 -$4.78M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.